CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol
-
Sep 22 2009
-
-
Source: Trials. 2009; 10:87.
[PDF-518.20 KB]
Details:
-
Alternative Title:Trials
-
Personal Author:
-
Description:Background
The objectives are to compare the effectiveness of cell phone-supported SMS messaging to standard care on adherence, quality of life, retention, and mortality in a population receiving antiretroviral therapy (ART) in Nairobi, Kenya.
Methods and Design
A multi-site randomized controlled open-label trial. A central randomization centre provided opaque envelopes to allocate treatments. Patients initiating ART at three comprehensive care clinics in Kenya will be randomized to receive either a structured weekly SMS ('short message system' or text message) slogan (the intervention) or current standard of care support mechanisms alone (the control). Our hypothesis is that using a structured mobile phone protocol to keep in touch with patients will improve adherence to ART and other patient outcomes. Participants are evaluated at baseline, and then at six and twelve months after initiating ART. The care providers keep a weekly study log of all phone based communications with study participants.
Discussion
This study protocol tests whether a novel structured mobile phone intervention can positively contribute to ART management in a resource-limited setting.
Trial Registration
Trial Registration Number: NCT00830622
-
Subjects:
-
Source:
-
Pubmed ID:19772596
-
Pubmed Central ID:PMC2760542
-
Document Type:
-
Place as Subject:
-
Volume:10
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
